Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Non-Current Assets (2016 - 2020)

China Pharma Holdings (CPHI) has disclosed Other Non-Current Assets for 8 consecutive years, with $222996.0 as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Other Non-Current Assets fell 55.69% year-over-year to $222996.0, compared with a TTM value of $222996.0 through Jun 2020, down 55.69%, and an annual FY2019 reading of $109908.0, down 91.37% over the prior year.
  • Other Non-Current Assets was $222996.0 for Q2 2020 at China Pharma Holdings, down from $331038.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.6 million in Q2 2017 and bottomed at $109908.0 in Q4 2019.
  • Average Other Non-Current Assets over 5 years is $1.1 million, with a median of $1.2 million recorded in 2018.
  • The sharpest move saw Other Non-Current Assets surged 104.92% in 2017, then plummeted 91.37% in 2019.
  • Year by year, Other Non-Current Assets stood at $1.1 million in 2016, then plummeted by 34.81% to $709796.0 in 2017, then soared by 79.48% to $1.3 million in 2018, then tumbled by 91.37% to $109908.0 in 2019, then surged by 102.89% to $222996.0 in 2020.
  • Business Quant data shows Other Non-Current Assets for CPHI at $222996.0 in Q2 2020, $331038.0 in Q1 2020, and $109908.0 in Q4 2019.